NCT05799898
- Conditions
- Cancer, Cardiovascular Complication, Immune Checkpoint Inhibitor, +2 more
- Locations
-
- Intitut Mutualiste Montsouris Paris, France
Clinical trial condition
Immune-related Adverse Event
Explore clinical trials studying Immune-related Adverse Event. Study availability and eligibility vary by location and protocol.
20 public trials
11 recruiting studies
Immune-related Adverse Event trial results
Not Yet Recruiting
Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor Therapy
NCT07663422
- Conditions
- Immune-mediated Hepatitis, Immune-related Adverse Event
- Locations
-
Not specified
Not Yet Recruiting
Safety, Virological and Immunological Assessment of the Controlled Dengue Human Infection Model in Dengue-Immune Participants in Thailand (DHIT-Immune)
NCT06908018
- Conditions
- Arbovirus Infections, Dengue, Flaviviridae Infections, +15 more
- Locations
-
Not specified
Not Yet Recruiting
Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis
NCT06785974
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +15 more
- Locations
-
- Erasmus Universitair Medisch Cetrum Rotterdam Rotterdam, South Holland, Netherlands
Completed
Rheumatic IMmune-Related Adverse Events in Patients Treated With Immune Check Point Inhibitors
NCT05544292
- Conditions
- Arthritis, Immune-related Adverse Event, Joint Diseases, +1 more
- Locations
-
- Ålesund Hospital Ålesund, Norway
- Hospital of Southern Norway Trust Kristiansand, Norway
- Levanger Hospital Levanger, Norway
- Diakonhjemmet Hospital Oslo, Norway
Completed
Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology
NCT03948724
- Conditions
- Adenocarcinoma, Advanced Non-Small Cell Lung Cancer, Carcinoma, +29 more
- Locations
-
- Chu Angers Angers, France
- Institut de Cancerologie de L'Ouest Angers, France
- Centre Francois Baclesse Caen, France
- Centre D'Oncologie Et de Radiotherapie 37 Chambray-lès-Tours, France
NCT06440811
- Conditions
- Chemotherapeutic Toxicity, Gastric or Gastroesophageal Junction Adenocarcinoma, Immune-related Adverse Event
- Locations
-
- Tangdu hospital Xi'an, Shaanxi, China
- Shaanxi Provincial People's Hospital Xi'an, Shaanxi, China
- Xijing hospital Xi'an, Shaanxi, China
Completed
Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy
NCT06089967
- Conditions
- Cancer, Immune-related Adverse Event, Neoplasms
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
NCT05934214
- Conditions
- Cancer, Immune Checkpoint Inhibitor-Related Myocarditis, Immune-related Adverse Event, +1 more
- Locations
-
- AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM. Paris, France
- CIC Paris-Est / Institut Curie Paris, France
Active, Not Recruiting
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
NCT04305145
- Conditions
- Chemically-Induced Disorders, Colitis, Colonic Diseases, +24 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States